Substance / Medication

Isoxsuprine

Overview

Active Ingredient
isoxsuprine
RxNorm CUI
6066

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

3 trials linked to this intervention

3
Total Trials
1
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Use of isoxsuprine hydrochloride as a tocolytic agent in the treatment of preterm labour: a systematic review of previous literature.
Giorgino Francesco Libero, Egan Colin Gerard · Arzneimittelforschung · 2010
PMID: 20712130Meta-Analysis
Pharmacokinetics of isoxsuprine hydrochloride administered orally and intramuscularly to female healthy volunteers.
Marzo Antonio, Zava Dario, Coa Katrin et al. · Arzneimittelforschung · 2009
PMID: 19856793RCT
Comparing the predictability of different chemometric models over UV-spectral data of isoxsuprine and its toxic photothermal degradation products.
Saad Ahmed S, Elzanfaly Eman S, Halim Michael K et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2019
PMID: 31063959Observational
Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis.
Bhadage Chetan J, Umarji Hemant R, Shah Karan et al. · Clin Oral Investig · 2013
PMID: 22893038Observational
Enantioseparation of chiral vasodilator drug isoxsuprine in high-performance liquid chromatography and capillary electrophoresis.
Chankvetadze Bezhan, Burjanadze Naira, Blaschke Gottfried · J Pharm Biomed Anal · 2002
PMID: 11682221Observational
Investigation of the clinical effects of isoxsuprine hydrochloride administered before cesarean section in sheep on mother and newborn.
Yaprakci Ömer, Akkuş Tuğra, Emre Birten · Res Vet Sci · 2025
PMID: 40117954Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Isoxsuprine (substance)
SNOMED CT
372818004
UMLS CUI
C0022267
RxNorm CUI
6066

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.